Patrick Daly

Cancer Nursing Today nonprod

According to a report in Frontiers in Immunology, nascent data suggest that vitamin D receptor (VDR) deficiency is a major factor in inflammatory bowel disease pathology. The report&rsquo;s authors also noted, however, that no evidence on intestinal expression of VDR after allogeneic hematopoietic cell transplantation (HCT) has been presented.Based on analyses of intestinal biopsies, researchers revealed what appeared to be an &ldquo;essential role&rdquo; of VDR gene expression in the pathology of gastrointestinal <a href="https://cancernursingtoday.com/post/msc-dysfunction-after-hct-associated-with-gvhd-onset">graft-versus-host disease</a> (GI-GVHD), as well as the prognosis of recipients of HCT.<h3>Vitamin D Receptor Deficiency Drives GI-GVHD</h3>The study included gastrointestinal biopsies from 90 adult patients (small intestine, 33; large intestine, 57) who underwent HCT between October 2009 and November 2013. At the time of collection, 57 patients showed no symptoms of gut GVHD (median days after HCT, 62), 24 patients showed symptoms suggestive of GVHD onset (median days after HCT, 78), and 9 patients had persistent or recurrent acute GVHD (median days after HCT, 175).Patients with severe acute GI-GVHD had significant downregulation of VDR gene expression compared with patients with mild or no acute GVHD (P=.007). In addition, VDR downregulation was observed at the onset of acute GVHD compared with patients without GVHD (P=.01). Via immunohistochemistry, the authors also found reduced VDR+ cells (P=.03) and VDR staining scores (P=.02) in patients with severe acute GI-GVHD relative to patients with mild or no GVHD, reaffirming their VDR findings.Of note, low gene expression of VDR was associated with a greater cumulative incidence of treatment-related mortality (P=.0000016), but not relapse-related mortality. Cox regression models found a 4-fold increased risk for treatment-related mortality in patients with low VDR (hazard ratio, 4.14; 95% CI, 1.78-9.63; P=.001).&ldquo;In this study, we present clinical evidence suggesting that the VDR plays a critical and multifaceted role in acute GI-GVHD and mortality,&rdquo; the authors summarized. They added that high-dose vitamin D3 supplementation could be a potential rescue therapy for patients with low VDR.<a href="https://cancernursingtoday.com/category/gvhd">Read More Recent Reports on GVHD</a>

Vitamin D Receptor Deficiency Predicts Poor HCT Outcomes

GVHD

Vitamin D receptor deficiency appeared to play a major role in the pathology of gastrointestinal graft-versus-host disease.

About Us

Editorial Policy

Authors

Advertising

eNewsletters

Contact Us

Contribute

Calendar of Events

Career Center

Blood Cancers Today

GU Oncology Now

DocWire News

MashupMD

Urban Health Today

Breast Cancer

Colorectal Cancer

GI Cancer

GU Cancer

Gynecologic Cancer Awareness Month

Gyn-Onc

Blood Cancer Awareness Month

Leukemia

Lymphoma

Myeloproliferative Neoplasms

Multiple Myeloma

Myelodysplastic Syndrome

Myelofibrosis

Sickle Cell

Hem/Onc

Professional Development

Patient Voice

Lung Cancer

Skin Cancer

Other Tumor Types

News

Treatment

More

Conferences

Calendar

CARE Award

Best Practices

Expert Interviews

Subscribe